US 6,310,085 B1Granted

Method for the treatment of neurological or neuropsychiatric disorders

AssigneeClarencew Pty Ltd.

InventorGregory Lynn Willis

Life of this patent

Estimating the term…

Abstract

This invention relates to a method for the treatment and/or prophylaxis of a neurological or neuropsychiatric disorder associated with altered dopamine function which comprises subjecting a patient in need thereof to therapy which blocks and/or inhibits melatonin, precursors thereof and/or metabolic products thereof.

Claims20

Dependent claims

A method for the treatment and/or prophylaxis of a neurological or neuropsychiatric disorder associated with altered dopamine function which comprises administering to a patient in need of such treatment or prophylaxis an effective amount of a compound of formula (1)

where X is —NO2 or —N3 and Y is H or I.

Dependencies are inferred from the claim text.

Facts

Application: 09/285,859Filed 2 Apr 1999 · continuation in part
Priority: 3 Oct 1997
Granted: 30 Oct 2001
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/40
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with one nitrogen as the only ring hetero atom,…
A61K 31/165
Amides, e.g. hydroxamic acids: having aromatic rings, e.g. colchicine, atenolol, progabide
A61K 31/17
Amides, e.g. hydroxamic acids: having the group >N—C—N< or >N—C—N<, e.g. urea, thiourea, carmustine
A61K 31/4045
Indoles, e.g. pindolol: indole-alkylamines; Amides thereof, e.g. serotonin, melatonin

Family

PCT/AU97/00661Parent of this continuation-in-part · filed 3 Oct 1997
US 6,310,085 B1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results